MedPath

UNIVERSITY OF UTAH

UNIVERSITY OF UTAH logo
🇺🇸United States
Ownership
Private
Established
1850-02-28
Employees
10K
Market Cap
-
Website
http://www.utah.edu

Inflammatory Cytokine Quantification in Infants

Completed
Conditions
Neonatal Cardiopulmonary Failure
Congenital Diaphragmatic Hernia
Sepsis
First Posted Date
2010-07-02
Last Posted Date
2015-05-04
Lead Sponsor
University of Utah
Target Recruit Count
21
Registration Number
NCT01155830
Locations
🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

🇺🇸

University of Utah, Salt Lake City, Utah, United States

DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation

Completed
Conditions
Atrial Fibrillation
Interventions
Procedure: DE-MRI
First Posted Date
2010-06-24
Last Posted Date
2017-06-02
Lead Sponsor
University of Utah
Target Recruit Count
339
Registration Number
NCT01150214
Locations
🇺🇸

University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

🇫🇷

Hôpital Cardiologique du Haut-Lévêque/Bordeaux, Bordeaux, France

🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

and more 12 locations

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

Phase 1
Completed
Conditions
Acute Myeloid Leukemia
AML
Interventions
First Posted Date
2010-06-23
Last Posted Date
2015-10-07
Lead Sponsor
University of Utah
Target Recruit Count
3
Registration Number
NCT01149408
Locations
🇺🇸

University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Phase 1
Terminated
Conditions
Cancer
Colon Cancer
Neuroendocrine
Ovarian Cancer
Interventions
Drug: JI-101
Drug: Everolimus
First Posted Date
2010-06-23
Last Posted Date
2014-10-06
Lead Sponsor
University of Utah
Target Recruit Count
19
Registration Number
NCT01149434
Locations
🇺🇸

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease

Completed
Conditions
Congenital Heart Disease
Prematurity
Necrotizing Enterocolitis
First Posted Date
2010-05-19
Last Posted Date
2013-08-13
Lead Sponsor
University of Utah
Target Recruit Count
6
Registration Number
NCT01126372
Locations
🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

Lidocaine Analgesia For Removal Of Wound Vac Dressings

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: Lidocaine
Drug: Placebo-Saline
First Posted Date
2010-05-19
Last Posted Date
2014-05-29
Lead Sponsor
University of Utah
Target Recruit Count
11
Registration Number
NCT01126359
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Completed
Conditions
Venothromboembolism
First Posted Date
2010-04-20
Last Posted Date
2014-10-31
Lead Sponsor
University of Utah
Target Recruit Count
26
Registration Number
NCT01107327
Locations
🇺🇸

University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States

Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure

Phase 1
Completed
Conditions
Blood Pressure
Interventions
Drug: Provex CV
Other: placebo
First Posted Date
2010-04-19
Last Posted Date
2015-01-14
Lead Sponsor
University of Utah
Target Recruit Count
20
Registration Number
NCT01106170
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults

Not Applicable
Completed
Conditions
Upper Respiratory Tract Infections Due to Influenza or Rhinovirus
Interventions
Dietary Supplement: transfer factor
Dietary Supplement: Placebo
First Posted Date
2010-04-19
Last Posted Date
2011-11-16
Lead Sponsor
University of Utah
Target Recruit Count
49
Registration Number
NCT01106183
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Inflammatory Syndromes

Suspended
Conditions
Prematurity
Necrotizing Enterocolitis
First Posted Date
2010-04-19
Last Posted Date
2020-02-05
Lead Sponsor
University of Utah
Target Recruit Count
60
Registration Number
NCT01106209
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath